HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,172 | +4.3% | 10,129 | -7.3% | 0.00% | +33.3% |
| Q2 2023 | $1,124 | +0.9% | 10,928 | +7.0% | 0.00% | -25.0% |
| Q1 2023 | $1,114 | -98.6% | 10,211 | -98.5% | 0.00% | -98.6% |
| Q4 2022 | $77,828 | -99.9% | 683,900 | -36.0% | 0.28% | +6.9% |
| Q3 2022 | $66,118,000 | +16.7% | 1,068,313 | +50.5% | 0.26% | +20.8% |
| Q2 2022 | $56,635,000 | -9.4% | 710,070 | +19.5% | 0.22% | -0.5% |
| Q1 2022 | $62,499,000 | +4.0% | 594,046 | +6.5% | 0.22% | +8.0% |
| Q4 2021 | $60,119,000 | +58.9% | 557,891 | +61.5% | 0.20% | +43.6% |
| Q3 2021 | $37,838,000 | +24.3% | 345,425 | +6.3% | 0.14% | +28.4% |
| Q2 2021 | $30,430,000 | +153.7% | 324,973 | +149.4% | 0.11% | +122.4% |
| Q1 2021 | $11,996,000 | +4215.1% | 130,327 | +3332.4% | 0.05% | +4800.0% |
| Q4 2020 | $278,000 | – | 3,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |